Detalles de la búsqueda
1.
FAD-dependent C-glycoside-metabolizing enzymes in microorganisms: Screening, characterization, and crystal structure analysis.
Proc Natl Acad Sci U S A
; 118(40)2021 10 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-34583991
2.
Oral formulation of bendamustine hydrochloride for patients with advanced solid tumors; a phase 1 study.
Invest New Drugs
; 41(1): 1-12, 2023 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-36331674
3.
Successful treatment of a case of hormone receptor-positive metastatic extramammary Paget disease with tamoxifen.
Invest New Drugs
; 40(1): 194-197, 2022 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-34463889
4.
Juzentaihoto Exerts Anti-Allergic Effects by Inhibiting Effector T-Cell Activation and Inducing and/or Activating Regulatory T Cells in a Murine Model of Contact Hypersensitivity.
Int Arch Allergy Immunol
; 183(1): 1-13, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-34818253
5.
Clinical Application of the FoundationOne CDx Assay to Therapeutic Decision-Making for Patients with Advanced Solid Tumors.
Oncologist
; 26(4): e588-e596, 2021 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-33325566
6.
Mutational activation of the epidermal growth factor receptor down-regulates major histocompatibility complex class I expression via the extracellular signal-regulated kinase in non-small cell lung cancer.
Cancer Sci
; 110(1): 52-60, 2019 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-30390416
7.
Multicentre, phase II study of eribulin in combination with S-1 in patients with advanced breast cancer.
BMC Cancer
; 19(1): 962, 2019 Oct 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-31619197
8.
Successful human epidermal growth receptor 2-targeted therapy beyond disease progression for extramammary Paget's disease.
Invest New Drugs
; 34(3): 394-6, 2016 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-26856856
9.
Takotsubo syndrome associated with coronary microvascular dysfunction: A case study.
J Cardiol Cases
; 29(3): 124-127, 2024 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-38481644
10.
Successful treatment with atezolizumab combination chemotherapy in a patient with high-grade fetal adenocarcinoma of the lung: A case report.
Thorac Cancer
; 14(2): 214-217, 2023 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36495048
11.
A Comprehensive Oral Intake Evaluation Tool (the Kuchi-kara Taberu Index) Facilitated Functional Eating Rehabilitation: A Case Report in a Frail Older Patient with Malnutrition and Suspected Iatrogenic Sarcopenia.
Gerontol Geriatr Med
; 8: 23337214221090284, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35434205
12.
Durable response to EGFR tyrosine kinase inhibitors in a patient with non-small cell lung cancer harboring an EGFR kinase domain duplication.
Thorac Cancer
; 12(16): 2283-2287, 2021 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-34240806
13.
C-Glycoside metabolism in the gut and in nature: Identification, characterization, structural analyses and distribution of C-C bond-cleaving enzymes.
Nat Commun
; 12(1): 6294, 2021 11 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-34728636
14.
Psychosocial effects of appearance changes due to cancer treatment and needs for information and supportive care in Japanese cancer patients.
Asia Pac J Clin Oncol
; 16(5): e185-e191, 2020 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-32285565
15.
Targeting of the HER2/HER3 signaling axis overcomes ligand-mediated resistance to trastuzumab in HER2-positive breast cancer.
Cancer Med
; 8(3): 1258-1268, 2019 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-30701699
16.
An HER3-targeting antibody-drug conjugate incorporating a DNA topoisomerase I inhibitor U3-1402 conquers EGFR tyrosine kinase inhibitor-resistant NSCLC.
Oncogene
; 38(9): 1398-1409, 2019 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-30302022
17.
A comparative study of curated contents by knowledge-based curation system in cancer clinical sequencing.
Sci Rep
; 9(1): 11340, 2019 08 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-31383922
18.
Heregulin expression and its clinical implication for patients with EGFR-mutant non-small cell lung cancer treated with EGFR-tyrosine kinase inhibitors.
Sci Rep
; 9(1): 19501, 2019 12 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-31862929
19.
T790M-Selective EGFR-TKI Combined with Dasatinib as an Optimal Strategy for Overcoming EGFR-TKI Resistance in T790M-Positive Non-Small Cell Lung Cancer.
Mol Cancer Ther
; 16(11): 2563-2571, 2017 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-28839001
20.
Progression-Free and Overall Survival of Patients With ALK Rearrangement-Positive Non-Small Cell Lung Cancer Treated Sequentially With Crizotinib and Alectinib.
Clin Lung Cancer
; 17(6): 528-534, 2016 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-27318655